NextCure, Inc. (NXTC)
NASDAQ·Healthcare·Biotechnology
$4.79
-7.53%
Mkt Cap $24.71M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+317.5%
Consensus $20.00 vs current $4.79
NASDAQ·Healthcare·Biotechnology
$4.79
-7.53%
Mkt Cap $24.71M
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
+317.5%
Consensus $20.00 vs current $4.79